AJP - Cell Physiology, Vol 271, Issue 3 C905-C913, Copyright © 1996 by American Physiological Society

ARTICLES

Identification of muscarinic receptor subtypes in mouse parotid gland

E. L. Watson, P. W. Abel, D. DiJulio, W. Zeng, M. Makoid, K. L. Jacobson, L. T. Potter and F. J. Dowd
Department of Oral Biology, University of Washington, Seattle 98195, USA.

Immunoprecipitation of muscarinic receptors from mouse parotid membranes by specific subtype antisera showed that M3 and M1 receptors represented 75 and 15% of the total number of precipitable receptors, respectively. [N-methyl-3H]methylscopolamine (NMS) labeled a single class of high-affinity binding sites in membranes from parotid glands with a dissociation constant of 0.67 +/- 0.02 nM and a maximum binding capacity of 176 +/- 15 fmol/mg protein. Competition curves for NMS, atropine, 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) and para-fluoro-hexahydro-sila-difenidol fit best to a one-site binding model, whereas pirenzepine and methoctramine fit best to a two-site binding model, indicating 76-90% M3 receptors. Results from the use of pirenzepine indicated that the second mouse parotid receptor subtype, unlike that of the submandibular gland, has atypical characteristics for an M1 receptor. The rank order of potency of muscarinic antagonists in inhibiting phosphoinositide turnover and biphasic effects of carbachol on isoproterenol-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) accumulation was atropine > or = 4-DAMP >> pirenzepine > AF-DX 116. A specific M1 antagonist, m1-toxin, had no effect on carbachol augmentation or inhibition of isoproterenol responses. Results suggest that M3 receptors couple to both augmentation and inhibition of stimulated cAMP levels.

This article has been cited by other articles:

				A. L. Lin, B. Zhu, W. Zhang, H. Dang, B.-X. Zhang, M. S. Katz, and C.-K. Yeh Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1454 - C1464. [Abstract] [Full Text] [PDF]

				G. Tobin, A. T. Ryberg, S. Gentle, and A. V. Edwards Distribution and function of muscarinic receptor subtypes in the ovine submandibular gland J Appl Physiol, April 1, 2006; 100(4): 1215 - 1223. [Abstract] [Full Text] [PDF]

				D. Plourde and S. P. Soltoff Ouabain potentiates the activation of ERK1/2 by carbachol in parotid gland epithelial cells; inhibition of ERK1/2 reduces Na+-K+-ATPase activity Am J Physiol Cell Physiol, March 1, 2006; 290(3): C702 - C710. [Abstract] [Full Text] [PDF]

				C. S. Bockman, M. E. Bradley, H. K. Dang, W. Zeng, M. A. Scofield, and F. J. Dowd Molecular and Pharmacological Characterization of Muscarinic Receptor Subtypes in a Rat Parotid Gland Cell Line: Comparison with Native Parotid Gland J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 718 - 726. [Abstract] [Full Text]

				W. Luo, L. R. Latchney, and D. J. Culp G protein coupling to M1 and M3 muscarinic receptors in sublingual glands Am J Physiol Cell Physiol, April 1, 2001; 280(4): C884 - C896. [Abstract] [Full Text] [PDF]

				E. L. Watson, Z. Wu, K. L. Jacobson, D. R. Storm, J. C. Singh, and S. M. Ott Capacitative Ca2+ entry is involved in cAMP synthesis in mouse parotid acini Am J Physiol Cell Physiol, March 1, 1998; 274(3): C557 - C565. [Abstract] [Full Text] [PDF]